Literature DB >> 15499547

Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection.

Jerome Pacanowski1, Leyla Develioglu, Isabelle Kamga, Martine Sinet, Moïse Desvarieux, Pierre-Marie Girard, Anne Hosmalin.   

Abstract

During human immunodeficiency virus (HIV) infection, interruption of highly active antiretroviral therapy (HAART) is usually followed by virus load rebound. Previous data have suggested a role for plasmacytoid dendritic cells (pDCs) in anti-HIV innate immunity. Here, the number of pDCs was measured by flow cytometry before, during, and after receipt of HAART in 7 patients with documented primary HIV-1 infection. A negative correlation was evidenced between pDC counts after 1 month of HAART and mean plasma virus load after interruption of HAART (r2=0.85; Spearman's partial rho =-0.92; P=.03). pDC counts during treatment might help predict immune replication control after interruption of HAART.

Entities:  

Mesh:

Year:  2004        PMID: 15499547     DOI: 10.1086/425020

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy.

Authors:  Barbara Schmidt; Sue H Fujimura; Jeffrey N Martin; Jay A Levy
Journal:  J Clin Immunol       Date:  2006-01       Impact factor: 8.317

2.  Plasmacytoid dendritic cells reduce HIV production in elite controllers.

Authors:  K Machmach; M Leal; C Gras; P Viciana; M Genebat; E Franco; F Boufassa; O Lambotte; J P Herbeuval; E Ruiz-Mateos
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.

Authors:  Elena Martinelli; Claudia Cicala; Donald Van Ryk; Diana J Goode; Katilyn Macleod; James Arthos; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

4.  Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.

Authors:  Emmanouil Papasavvas; Andrea Foulkes; Xiangfan Yin; Jocelin Joseph; Brian Ross; Livio Azzoni; Jay R Kostman; Karam Mounzer; Jane Shull; Luis J Montaner
Journal:  Immunology       Date:  2015-05-19       Impact factor: 7.397

5.  Rapid disease progression in HIV-1-infected men who have sex with men is negatively correlated with peripheral plasmacytoid dendritic cell counts at the early stage of primary infection.

Authors:  Wenqing Geng; Xuejie Fan; Yingying Diao; Hualu Cui; Hong Sun; Ke Yun; Junjie Xu; Min Zhang; Yanan Wang; Zining Zhang; Hong Shang
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

6.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.

Authors:  Anne-Sophie Beignon; Kelli McKenna; Mojca Skoberne; Olivier Manches; Ida DaSilva; Daniel G Kavanagh; Marie Larsson; Robert J Gorelick; Jeffrey D Lifson; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

7.  Plasmacytoid dendritic cells accumulate and secrete interferon alpha in lymph nodes of HIV-1 patients.

Authors:  Clara Lehmann; Mark Lafferty; Alfredo Garzino-Demo; Norma Jung; Pia Hartmann; Gerd Fätkenheuer; Jeffrey S Wolf; Jan van Lunzen; Fabio Romerio
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells.

Authors:  Sabrina Haupt; Norbert Donhauser; Chawaree Chaipan; Philipp Schuster; Bridget Puffer; Rod S Daniels; Thomas C Greenough; Frank Kirchhoff; Barbara Schmidt
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

9.  Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques.

Authors:  Benoît Malleret; Ingrid Karlsson; Benjamin Manéglier; Patricia Brochard; Benoît Delache; Thibault Andrieu; Michaela Muller-Trutwin; Tim Beaumont; Joseph M McCune; Jacques Banchereau; Roger Le Grand; Bruno Vaslin
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

10.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.